Search Results

Displaying Results 4851-4875 of 6964 "'J'"

Oct 20, 2025, 09:07 ET GAIRDNER SCIENCE WEEK BRINGS GLOBAL SCIENTIFIC EXPERTS TO CANADA TO CELEBRATE RESEARCH IMPACTING HUMAN HEALTH

International Symposium (9:00AM-1:00PM EDT, Toronto & Online)Celebrating 2025 Canada Gairdner International Award laureates, Drs. Michael J. Welsh and Paul Negulescu, whose pioneering cystic fibrosis research has catalyzed life-changing therapies.

More news about: Gairdner Foundation

Oct 20, 2025, 09:00 ET $10 Million James F. Lu World Fellows Program to support up to 55 students pursuing PhD degrees

The nation and University of Michigan have long benefited from our ability to draw top talent from across the globe," said Karen A. Thole, the Robert J. Vlasic Dean of Engineering. "This generous gift will help continue that tradition, as we work at Michigan Engineering to solve today's pressing challenges

More news about: James F. Lu

Oct 20, 2025, 09:00 ET RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal

Howden C, Moss S, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024;119:1730-53. 3 Chey et al. Am J Gastroenterol. 2024 4

More news about: RedHill Biopharma Ltd.

Oct 20, 2025, 08:40 ET Lupus Research Alliance Applauds U.S. FDA Approval of Gazyva® (Obinutuzumab) for Lupus Nephritis

the program. "True progress in clinical research is only possible when those impacted are a part of the entire process," Stacie J. Bell, PhD, Chief Clinical Research Officer of Lupus Therapeutics. "With patients heard throughout the development of Gazyva, it is encouraging to see

More news about: Lupus Research Alliance

Oct 20, 2025, 08:37 ET Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch

efforts complement the Company's ongoing commercialization activities, including inventory readiness, market access infrastructure, permanent J-code assignment (J9161), NCCN guideline inclusion, and a robust suite of provider and patient education resources. About

More news about: Citius Oncology, Inc.

Oct 20, 2025, 08:30 ET From Signals to Strategy: The Next Chapter of Digital Biomarkers, Upcoming Webinar Hosted by Xtalks

Comparative Pathobiology, and Epidemiology, Johns Hopkins University; Raha Dastgheyb, Assistant Professor of Neurology, Johns Hopkins School of Medicine; Bryan J. Hansen, PhD, Pharma Neuroscientist, Technologist, and Innovator; Tairmae Kangarloo, former Associate Director Digital Strategy; and David Anderson, Director,

More news about: Xtalks

Oct 20, 2025, 08:00 ET Construction Partners, Inc. Completes Florida Acquisition

be part of CPI's platform company, C.W. Roberts Contracting, Incorporated, which operates throughout the State of Florida. Fred J. (Jule) Smith, III, the Company's President and Chief Executive Officer, said, "This transaction expands our footprint into several markets and enhances

More news about: Construction Partners, Inc.

Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor

23;391(10139):2513-2524. Rubbert-Roth A, Enejosa J, Pangan AL, Haraoui B, Rischmueller M, Khan N, Zhang Y, Martin N, Xavier RM. Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. N Engl J Med. 2020 Oct 15;383(16):1511-1521. Fleischmann

More news about: AbbVie

Oct 20, 2025, 07:00 ET CITY OF LONDON INVESTMENT GROUP PLC ("City of London" or "the Group" or "the Company" or "CLIG") TRADING UPDATE FOR THE QUARTER TO 30 SEPTEMBER 2025

universe continues to offer an attractive investment proposition and we continue to see interest from allocators looking to either manage their overall J-Curve exposure to private equity or as a listed and liquid component to their private markets allocations. The International Equity

More news about: City of London Investment Group PLC

Collective Mining Provides an Exploration Update: Significant Visual Mineralization Intersected in Expansion Drilling at Both the Guayabales and San Antonio Projects

Oct 20, 2025, 07:00 ET Collective Mining Provides an Exploration Update: Significant Visual Mineralization Intersected in Expansion Drilling at Both the Guayabales and San Antonio Projects

symbol "CNL". Qualified Person (QP) and NI43-101 Disclosure David J Reading is the designated Qualified Person for this news release within the meaning of National Instrument 43-101 ("NI 43-101") and has reviewed and verified

More news about: Collective Mining Ltd.

Oct 20, 2025, 06:30 ET IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma in a Proffered Paper Oral Presentation at ESMO 2025

similar decrease in radiation to the tumor apex is associated with improved visual outcomes (Perez et al, Int J Radiat Oncol Biol Phys. 2014; Kheir et al, Adv Radiat Oncol. 2022; Saconn et al, Int J Radiat Oncol Biol Phys. 2010; Puusaari et al, Invest Ophthalmol Vis Sci. 2004).64.9% (24/37) of the evaluable

More news about: IDEAYA Biosciences, Inc.